BioSpace News Archive

A statement by President and CEO of the MHCC welcoming MPs to Ottawa, highlighting the importance of self-care during times of transition

Congratulations to all 338 MPs elected to represent your constituencies in Ottawa in the 43rd Parliament

October 23, 2019
·
1 min read
Policy

Tauriga Sciences, Inc. Comments on Recent Activity Related to Unauthorized Third-Party Stock Promotion Materials Referencing the Company

The Company became aware of three such firms that released unauthorized materials

October 23, 2019
·
6 min read
BioMidwest

Healthx Introducing OXP Omnichannel Experience Platform at HLTH 2019

Automated consumer-centric engagement capability to debut at industry event

October 23, 2019
·
3 min read
BioMidwest

New Prostate Cancer Care Team Web Portal Provides Resources for Managing the Disease

Prostate cancer nonprofit Us TOO International, in partnership with numerous professional healthcare member organizations, announces the launch of The Prostate Cancer Care Team Hub – an educational website portal for men living with prostate cancer.

October 23, 2019
·
3 min read
Biotech Bay

Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The stock option has an exercise price of $1.94 per share, which is equal to the closing price of Zosano’s common stock on the grant date, October 21, 2019.

October 23, 2019
·
1 min read
Business

Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings

Newly Formed Clinical-Stage Biotechnology Company to Develop Treatments for Rare Pediatric Neurodegenerative Diseases

October 23, 2019
·
6 min read
Business

Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results

The company will provide a live conference call and webcast to discuss these financial results on Thursday, November 7, 2019 at 8:30 AM ET.

October 23, 2019
·
2 min read
Business

Puma Biotechnology to Host Conference Call to Discuss 2019 Third Quarter Financial Results

Puma Biotechnology, Inc., a biopharmaceutical company, will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Wednesday, November 6, 2019 following release of its third quarter 2019 financial results..

October 23, 2019
·
2 min read
Business

bluebird bio Announces Transition of Chief Strategy Officer Jeffrey T. Walsh

Jeffrey T. Walsh, chief strategy officer, has decided to transition from his current role effective January 6, 2020.

October 23, 2019
·
4 min read
Deals

Charles River Laboratories Announces Closing of Senior Notes Offering - Oct. 23, 2019

Charles River Laboratories International, Inc. announced that it has closed its previously announced offering of $500 million in aggregate principal amount of its 4.25% senior notes due 2028 in an unregistered offering.

October 23, 2019
·
3 min read